The Prognostic Value of Lymphovascular Invasion in Combination with Nodal Stage on Disease-specific Survival in Patients with Bladder Cancer Following Upfront Radical Cystectomy
European Urology Focus · 2026-10
DOI: 10.1016/j.euf.2026.09.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Urology Focus, 2026-10. Verfasst von Erik J van Gennep und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of …. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EAU.
Abstract (Originalsprache)
The prognostic value of lymphovascular invasion (LVI) after radical cystectomy (RC) remains debated, particularly in relation to pathological tumor stage (pT) and pathological nodal status (pN). We analyzed the strongest prognostic factors for disease-specific survival (DSS) in a multicenter study with local pathology review, including 1229 patients with cT1-4aN0M0 urothelial bladder cancer (BC) treated with upfront RC (1986-2020). A classification and regression tree (CART) analysis was used to prioritize prognostic variables. CART identified pN status as the primary discriminator, followed by LVI as the second strongest prognostic factor within pN-negative disease. LVI was present in 584 patients (48%). Median follow-up was 4.1 yr. In multivariable Cox regression models, LVI was independently associated with DSS in both the pN-negative (hazard ratio [HR] 1.50, 95% confidence interval (CI) = 1.16-1.94; p = 0.002) and pN-positive (HR 1.38, 95%CI = 1.04-1.83; p = 0.03) cohorts. CART defined three prognostic groups: favorable prognosis (pN negative/LVI negative), intermediate prognosis (pN negative/LVI positive), and poor prognosis (pN positive), with 5-yr DSS of 65%, 48%, and 25%, respectively. Among patients with poor prognosis, adjuvant chemotherapy (AC) was associated with longer DSS (HR 0.47; p < 0.001). In the intermediate-prognosis group, receipt of AC was not statistically associated with DSS (HR 0.66, 95%CI 0.39-1.10; p = 0.10). Combined assessment of pN status and LVI provides clinically meaningful postoperative risk stratification that may help refine postoperative risk assessment, surveillance planning, and multidisciplinary discussion regarding adjuvant treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Leiden University Medical Center, Leiden, The Netherlands. El…
- Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Leiden University Medical Center, Leiden, The Netherlands; Ur…
- Department of Urology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Surgery (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada; Department of Urology, Turku University Hospital and University of Turku, Turku, Finla…
- Department of Urology, University of Texas Southwestern Medical Center, Dallas, USA; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornel…
- Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Institut Curie, CNRS, UMR144, Molecular Oncology Team, PSL Research University, Pari…
Förderung
- EAU
Zitieren
APA
van Gennep, E. J., Claps, F., KleinJan, G. H., Bostrom, P. J., Shariat, S. F., Neuzillet, Y., Zlotta, A. R., Amodeo, A., Eckstein, M., Mertens, L. S., Bussani, R., Burger, M., Boormans, J. L., Wullich, B., Contieri, R., Hartmann, A., Mayr, R., Trombetta, C., Pavan, N., …, & van Rhijn, B. W. G. (2026). The Prognostic Value of Lymphovascular Invasion in Combination with Nodal Stage on Disease-specific Survival in Patients with Bladder Cancer Following Upfront Radical Cystectomy. European Urology Focus. https://doi.org/10.1016/j.euf.2026.09.004
Vancouver
van Gennep EJ, Claps F, KleinJan GH, Bostrom PJ, Shariat SF, Neuzillet Y, et al. The Prognostic Value of Lymphovascular Invasion in Combination with Nodal Stage on Disease-specific Survival in Patients with Bladder Cancer Following Upfront Radical Cystectomy. European Urology Focus. 2026. doi:10.1016/j.euf.2026.09.004
BibTeX
@article{vanGennep2026,
author = {van Gennep, Erik J and Claps, Francesco and KleinJan, Gijs H and Bostrom, Peter J and Shariat, Shahrokh F and Neuzillet, Yann and Zlotta, Alexandre R and Amodeo, Antonio and Eckstein, Markus and Mertens, Laura S and Bussani, Rossana and Burger, Maximilian and Boormans, Joost L and Wullich, Bernd and Contieri, Roberto and Hartmann, Arndt and Mayr, Roman and Trombetta, Carlo and Pavan, Nicola and Porreca, Angelo and Mir, M Carmen and Pouessel, Damien and Roshani, Hossain and van der Kwast, Theo H and Allory, Yves and Zuiverloon, Tahlita C M and van Leenders, Geert J L H and Lotan, Yair and van Rhijn, Bas W G},
title = {The Prognostic Value of Lymphovascular Invasion in Combination with Nodal Stage on Disease-specific Survival in Patients with Bladder Cancer Following Upfront Radical Cystectomy},
journal = {European Urology Focus},
year = {2026},
doi = {10.1016/j.euf.2026.09.004}
}
EUVIMED